The purpose of this study is to evaluate the efficacy, safety and tolerability of ISIS-GCGRRx in combination with metformin versus placebo + metformin
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
77
3 doses on alternate days during the first week and then once weekly for 12 weeks
3 doses on alternate days during the first week and then once weekly for 12 weeks
3 doses on alternate days during the first week and then once weekly for 12 weeks
Isis Investigational Site
Birmingham, Alabama, United States
The effect of ISIS-GCGRRx on serum fructosamine
Change from Baseline to Week 14
Time frame: 14 Weeks
The safety of ISIS-GCGRRx
By determining the incidence, severity, dose-relationship adverse effects, and changes in laboratory evaluations
Time frame: 25 Weeks
The tolerability of ISIS-GCGRRx
By determining the incidence, severity, dose-relationship adverse effects, and changes in laboratory evaluations
Time frame: 25 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Isis Investigational Site
Muscle Shoals, Alabama, United States
Isis Investigational Site
Anaheim, California, United States
Isis Investigational Site
Chino, California, United States
Isis Investigational Site
Los Angeles, California, United States
Isis Investigational Site
DeLand, Florida, United States
Isis Investigational Site
Fort Lauderdale, Florida, United States
Isis Investigational Site
Miami, Florida, United States
Isis Investigational Site
Marietta, Georgia, United States
Isis Investigational Site
Las Vegas, Nevada, United States
...and 14 more locations